Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing

Prostate cancer (PCa) is the second most common cancer in men. Common treatments include active surveillance, surgery, or radiation. Androgen deprivation therapy and chemotherapy are usually reserved for advanced disease or biochemical recurrence, such as castration-resistant prostate cancer (CRPC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahmad, Hisham F., Demus, Timothy, Moubarak, Maya M., Daher, Darine, Alvarez Moreno, Juan Carlos, Polit, Francesca, Lopez, Olga, Merhe, Ali, Abou-Kheir, Wassim, Nieder, Alan M., Poppiti, Robert, Omarzai, Yumna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883996/
https://www.ncbi.nlm.nih.gov/pubmed/35225948
http://dx.doi.org/10.3390/medsci10010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883996/
https://www.ncbi.nlm.nih.gov/pubmed/35225948
http://dx.doi.org/10.3390/medsci10010015

Ejemplares similares